Clicky

Cantargia AB(CANTA) News

Date Title
Oct 11 Cantargia Reports New Positive Results on Biomarkers and Safety in CAN10 Phase 1 Clinical Study
Oct 10 Cantargia’s Strong Phase 2 Clinical Data in Pancreatic Cancer with Nadunolimab Published in Clinical Cancer Research
May 23 Annual General Meeting in Cantargia AB (publ)
Feb 7 Invitation to Presentation of Cantargia’s Year-End Report 2023 on February 22 at 3.00 p.m. CET
Jan 9 Cantargia Reports Phase I Clinical Progress in the CAN10 Project
Nov 30 New Number of Shares and Votes in Cantargia